Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
447.49
-8.19 (-1.80%)
At close: Jul 25, 2025, 4:00 PM
451.77
+4.28 (0.96%)
After-hours: Jul 25, 2025, 7:42 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Oncology
651.24M
Log In
Log In
Log In
Log In
Upgrade
Oncology Growth
12.32%
Log In
Log In
Log In
Log In
Upgrade
Metabolic
457.54M
Log In
Log In
Log In
Log In
Upgrade
Metabolic Growth
31.89%
Log In
Log In
Log In
Log In
Upgrade
Other Sources of
431.38M
Log In
Log In
Log In
Log In
Upgrade
Other Sources of Growth
-2.99%
Log In
Log In
Log In
Log In
Upgrade
Cardiology
230.45M
Log In
Log In
Log In
Log In
Upgrade
Cardiology Growth
8.81%
Log In
Log In
Log In
Log In
Upgrade
Central Nervous System
181.98M
Log In
Log In
Log In
Log In
Upgrade
Central Nervous System Growth
18.97%
Log In
Log In
Log In
Log In
Upgrade
AVAI
156.46M
Log In
Log In
Log In
Log In
Upgrade
AVAI Growth
-24.92%
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net New Business Awards
2.23B
Log In
Log In
Log In
Log In
Upgrade
Net New Business Awards Growth
12.61%
Log In
Log In
Log In
Log In
Upgrade
Total Backlog
2.90B
Log In
Log In
Log In
Log In
Upgrade
Total Backlog Growth
-1.75%
Log In
Log In
Log In
Log In
Upgrade